Tarian Pharma
Tarian Pharma
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TAR-0520 Gel in Hand and Foot Syndrome | Chemically-Induced Disorders, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Skin and Connective Tissue Diseases, dermatitis, drug allergy, hand-foot syndrome, skin disorder | Not yet recruiting | Phase 2 | 2026-03-09 | NCT07457671 | |
| Safety and Efficacy Study of TAR-0520 Gel in Prevention of Taxane-induced Peripheral Neuropathy | Chemotherapy Induced Peripheral Neuropathy | Not yet recruiting | Phase 2 | 2025-07-24 | NCT07082764 | |
| TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis | EGFR Inhibitor-associated Rash | Recruiting | Phase 2 | 2025-02-10 | NCT06818058 |